Boston Scientific Corporation (BSX) Deep Dive Video

Summary

Boston Scientific’s sharp valuation reset offers a compelling but transitional medtech opportunity, balancing durable innovation-led growth against WATCHMAN softness, PFA competition, Penumbra integration risk, and elevated leverage.

View BSX stock page · Read the BSX research report

Loading the video player…